Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies David Malcom Rodman files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Brian Taylor Slingsby - $43.35M of MLYS open-market activity in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $38.76M of MLYS open-market activity in the last 12 months
- Srinivas Akkaraju - $15.00M of MLYS open-market activity in the last 12 months
- Jon Congleton - $14.38M of MLYS open-market activity in the last 12 months
- Adam Scott Levy - $5.82M of MLYS open-market activity in the last 12 months
- Eric Warren - $3.09M of MLYS open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is David Malcom Rodman?
David Malcom Rodman is a corporate insider, tracked as Chief Medical Officer of Mineralys Therapeutics, Inc. (MLYS). InsiderAlpha holds 28 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has David Malcom Rodman submitted recently?
6 primary Form 4 filings in the last 90 days, covering 1 company.
Has David Malcom Rodman been buying or selling stock?
Recorded transactions: 0 open-market purchases and 40 open-market sales ($6.06M) across all tracked filings.
Where can I see all of David Malcom Rodman's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow David Malcom Rodman and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
